REFRACTORY GOUT

Clinical trials for REFRACTORY GOUT explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY GOUT trials appear

Sign up with your email to follow new studies for REFRACTORY GOUT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for tough gout cases: experimental combo targets stubborn uric acid

Disease control Recruiting now

This study tests a new drug called AR882 combined with a standard gout medication (XOI) in 25 adults with uncontrolled gout who had severe reactions or failed uricase therapy. The goal is to lower uric acid levels below 6 mg/dL and shrink painful uric acid crystal deposits (tophi…

Matched conditions: REFRACTORY GOUT

Phase: PHASE2 • Sponsor: Arthrosi Therapeutics • Aim: Disease control

Last updated May 15, 2026 11:53 UTC

REFRACTORY GOUT

Get alerted when new REFRACTORY GOUT trials appear

New hope for tough gout cases: experimental combo targets stubborn uric acid